PROBLEMS
• A pregnant woman or a
woman who recently delivered complains of severe headache or blurred vision.
• A pregnant woman or a
woman who recently delivered is found unconscious or having convulsions
(seizures).
• A pregnant woman has
elevated blood pressure.
GENERAL MANAGEMENT
• If a woman is unconscious or convulsing, SHOUT FOR HELP.
Urgently mobilize all available personnel.
• Make a rapid evaluation of
the general condition of the woman including vital signs (pulse, blood pressure,
respiration) while simultaneously finding out the history of her present and
past illnesses either from her or from her relatives.
• If she is not breathing
or her breathing is shallow:
- Check airway and
intubate if required;
- If she is not
breathing, assist ventilation using Ambu bag and mask or give oxygen at
4–6 L per minute via endotracheal tube;
- If she is breathing,
give oxygen at 4–6 L per minute by mask or nasal cannulae.
• If she is unconscious:
- Check airway and
temperature;
- Position her on her left
side;
- Check for neck rigidity.
• If she is convulsing:
- Position her on her left
side to reduce the risk of aspiration of secretions, vomit and blood;
- Protect her from
injuries (fall), but do not attempt to restrain her;
- Provide constant
supervision;
- If eclampsia is
diagnosed (Table
S-9), give magnesium sulfate (Box S-3);
- If the cause of
convulsions has not been determined, manage as eclampsia and continue to
investigate other causes.
Table S-9 Diagnosis of
headache, blurred vision, convulsions or loss of consciousness, elevated blood
pressure
Presenting Symptom and Other Symptoms and Signs Typically
Present |
Symptoms and Signs Sometimes Present |
Probable Diagnosis |
•
Diastolic blood pressure 90 mm Hg or more before first 20 weeks of
gestation |
|
Chronic hypertension |
• Diastolic blood
pressure 90–110 mm Hg before 20 weeks of gestation
• Proteinuria up to 2+ |
|
Chronic hypertension with superimposed
mild pre-eclampsia |
• Two
readings of diastolic blood pressure 90–110 mm Hg 4 hours apart after 20
weeks gestation
• No proteinuria |
|
Pregnancy-induced hypertension |
• Two readings of
diastolic blood pressure 90–110 mm Hg 4 hours apart after 20 weeks
gestation
• Proteinuria up to 2+ |
|
Mild pre-eclampsia |
•
Diastolic blood pressure 110 mm Hg or more after 20 weeks gestation
• Proteinuria 3+ or more |
•
Hyperreflexia
• Headache (increasing frequency, unrelieved by regular analgesics)
• Clouding of vision
• Oliguria (passing less than 400 mL urine in 24 hours)
• Upper abdominal pain (epigastric pain or pain in right upper quadrant)
• Pulmonary oedema |
Severe pre-eclampsia |
• Convulsions
• Diastolic blood pressure 90 mm Hg or more after 20 weeks gestation
• Proteinuria 2+ or more |
• Coma (unconscious)
• Other symptoms and signs of severe pre-eclampsia |
Eclampsia |
• Trismus (difficulty
opening mouth and chewing) |
• Spasms of face, neck,
trunk
• Arched back
• Board-like abdomen
• Spontaneous violent spasms |
Tetanus |
• Convulsions
• Past history of convulsions
• Normal blood pressure |
|
Epilepsy |
• Fever
• Chills/rigors
• Headache
• Muscle/joint pain |
• Enlarged spleen |
Uncomplicated malaria |
• Symptoms and signs of
uncomplicated malaria
• Coma
• Anaemia |
• Convulsions
• Jaundice |
Severe/complicated malaria |
•
Headache
• Stiff neck
• Photophobia
• Fever |
•
Convulsions
• Confusion
• Drowsiness
• Coma |
Meningitisb,c or Encephalitisb,c |
• Headache
• Blurred vision |
• Vomiting |
Migrained |
a If a woman has
any one of the symptoms or signs listed under severe pre-eclampsia, diagnose
severe pre-eclampsia.
b If a diagnosis of eclampsia cannot be ruled out, continue
treatment for eclampsia.
c Examine spinal fluid and give appropriate treatment for
meningitis or encephalitis.
d Give analgesics (e.g. paracetamol 500 mg by mouth as needed).
Box S-2
Prevention of pregnancy-induced hypertension
• Restricting calories,
fluids and salt intake does NOT prevent pregnancy-induced hypertension
and may even be harmful to the fetus.
• The beneficial
effects of aspirin, calcium and other agents in preventing
pregnancy-induced hypertension have not yet been proven.
• Early detection
and management in women with risk factors is critical to the
management of pregnancy-induced hypertension and the prevention of
convulsions. These women should be followed up regularly and given clear
instructions on when to return to their health care provider. Education
of immediate family members is equally important, not only so that they
understand the significance of signs of pregnancy-induced hypertension
progression but also to increase social support when hospitalization and
changes in work activities are needed. |
DIAGNOSIS OF HYPERTENSIVE
DISORDERS
The hypertensive disorders
of pregnancy include pregnancy-induced hypertension and chronic hypertension
(elevation of the blood pressure before 20 weeks gestation). Headaches, blurred
vision, convulsions and loss of consciousness are often associated with
hypertension in pregnancy, but are not necessarily specific to it. Other
conditions that may cause convulsions or coma include epilepsy, complicated
malaria, head injury, meningitis, encephalitis, etc. See
Table S-9 for more information on diagnosis.
• Diastolic
blood pressure is a good indicator of prognosis for the management of
hypertensive disorders in pregnancy:
- Diastolic blood pressure
is taken at the point at which the arterial sound disappears:
- A falsely high reading
is obtained if the cuff does not encircle at least three-fourths of the
circumference of the arm;
- A wider cuff should be
used when the diameter of the upper arm is more than 30 cm;
- Diastolic blood pressure
measures peripheral resistance and does not vary with the woman’s emotional
state to the degree that systolic pressure does.
• If the diastolic blood
pressure is 90 mm Hg or more on two consecutive readings taken 4 hours or
more apart, diagnose hypertension (If urgent delivery must take place or
if the diastolic blood pressure is 110 mm Hg or more, a time interval of
less than 4 hours is acceptable):
- If hypertension occurs
after 20 weeks of gestation, during labour and/or within 48 hours of
delivery it is classified as pregnancy-induced hypertension;
- If hypertension occurs
before 20 weeks of gestation, it is classified as chronic hypertension.
PROTEINURIA
The presence of proteinuria
changes the diagnosis from pregnancy-induced hypertension to pre-eclampsia.
Other conditions cause proteinuria and false positive results are possible.
Urinary infection, severe anaemia, heart failure and difficult labour may all
cause proteinuria. Blood in the urine due to catheter trauma, schistosomiasis
and contamination from vaginal blood could give false positive results.
Random urine sampling such
as the dipstick test for protein is a useful screening tool. A change from
negative to positive during pregnancy is a warning sign. If dipsticks are not
available, a sample of urine can be heated to boiling in a clean test tube.
Add a drop of 2% acetic acid to check for persistent precipitates that can be
quantified as a percentage of protein to the volume of the total sample. Vaginal
secretions or amniotic fluid may contaminate urine specimens. Only clean-catch
mid-stream specimens should be used. Catheterization for this purpose is not
justified due to the risk of urinary tract infection.
Diastolic blood pressure
alone is an accurate indicator of hypertension in pregnancy. Elevated blood
pressure and proteinuria, however, define pre-eclampsia.
PREGNANCY-INDUCED
HYPERTENSION
Women with pregnancy-induced
hypertension disorders may progress from mild disease to a more serious
condition. The classes of pregnancy-induced hypertension are:
• hypertension without
proteinuria or oedema;
• mild pre-eclampsia;
• severe pre-eclampsia;
• eclampsia.
TABLE S-9 Diagnosis of headache, blurred vision, convulsions or loss of
consciousness, elevated blood pressure
A small proportion of women
with eclampsia have normal blood pressure. Treat all women with convulsions as
if they have eclampsia until another diagnosis is confirmed.
Remember:
• Mild pre-eclampsia often
has no symptoms.
• Increasing proteinuria is
a sign of worsening pre-eclampsia.
• Oedema of the feet and
lower extremities is not considered a reliable sign of pre-eclampsia.
In pregnancy-induced
hypertension, there may be no symptoms and the only sign may be hypertension.
• Mild pre-eclampsia may
progress rapidly to severe pre-eclampsia. The risk of complications, including
eclampsia, increases greatly in severe pre-eclampsia.
• Convulsions with signs of
pre-eclampsia indicates eclampsia. These convulsions:
- can occur regardless of
the severity of hypertension;
- are difficult to predict
and typically occur in the absence of hyperreflexia, headache or visual
changes;
- occur after childbirth
in about 25% of cases;
- are tonic-clonic and
resemble grand mal convulsions of epilepsy;
- may recur in rapid
sequence, as in status epilepticus, and may end in death;
- will not be observed if
the woman is alone;
- may be followed by coma
that lasts minutes or hours depending on the frequency of convulsions.
Do not give ergometrine to
women with pre-eclampsia, eclampsia or high blood pressure because it increases
the risk of convulsions and cerebrovascular accidents.
MANAGEMENT OF
PREGNANCY-INDUCED HYPERTENSION
Box S-2
Prevention of pregnancy-induced hypertension
• Restricting calories,
fluids and salt intake does NOT prevent pregnancy-induced hypertension and
may even be harmful to the fetus.
• The beneficial effects
of aspirin, calcium and other agents in preventing pregnancy-induced
hypertension have not yet been proven.
• Early detection and
management in women with risk factors is critical to the management of
pregnancy-induced hypertension and the prevention of convulsions. These
women should be followed up regularly and given clear instructions on when
to return to their health care provider. Education of immediate family
members is equally important, not only so that they understand the
significance of signs of pregnancy-induced hypertension progression but
also to increase social support when hospitalization and changes in work
activities are needed. |
PREGNANCY-INDUCED
HYPERTENSION
Manage on an outpatient
basis:
• Monitor blood pressure,
urine (for proteinuria) and fetal condition weekly.
• If blood pressure
worsens, manage as mild pre-eclampsia.
• If there are signs of
severe fetal growth restriction or fetal compromise, admit the woman to the
hospital for assessment and possible expedited delivery.
• Counsel the woman and her
family about danger signals indicating pre-eclampsia or eclampsia.
• If all observations
remain stable,
allow to proceed with normal labour and childbirth.
MILD PRE-ECLAMPSIA
GESTATION LESS THAN 37 WEEKS
If signs remain unchanged
or normalize, follow up twice a week as an outpatient:
• Monitor blood pressure,
urine (for proteinuria), reflexes and fetal condition.
• Counsel the woman and her
family about danger signals of severe pre-eclampsia or eclampsia.
• Encourage additional
periods of rest.
• Encourage the woman to eat
a normal diet (salt restriction should be discouraged).
• Do not give
anticonvulsants, antihypertensives, sedatives or tranquillizers.
• If follow-up as an
outpatient is not possible, admit the woman to the hospital:
- Provide a normal diet
(salt restriction should be discouraged);
- Monitor blood pressure
(twice daily) and urine for proteinuria (daily);
- Do not give
anticonvulsants, antihypertensives, sedatives or tranquillizers unless blood
pressure or urinary protein level increases;
- Do not give diuretics.
Diuretics are harmful and only indicated for use in pre-eclampsia with
pulmonary oedema or congestive heart failure;
- If the diastolic
pressure decreases to normal levels or her condition remains stable,
send the woman home:
- Advise her to rest and
to watch out for significant swelling or symptoms of severe pre-eclampsia;
- See her twice weekly
to monitor blood pressure, urine (for proteinuria) and fetal condition and
to assess for symptoms and signs of severe pre-eclampsia;
- If diastolic
pressure rises again, readmit her;
- If the signs remain
unchanged, keep the woman in the hospital. Continue the same management
and monitor fetal growth by symphysis-fundal height;
- If there are signs of
growth restriction, consider early delivery. If not, continue
hospitalization until term.
• If urinary protein
level increases, manage as severe pre-eclampsia (see below).
Note: Symptoms and
signs of pre-eclampsia do not completely disappear until after pregnancy ends.
GESTATION
MORE THAN 37 COMPLETE WEEKS
If there are signs of
fetal compromise,
assess the cervix and expedite delivery:
• If the cervix is
favourable (soft, thin, partly dilated),
rupture the membranes with an amniotic hook or a Kocher clamp and induce labour
using oxytocin or prostaglandins.
• If the cervix is
unfavourable (firm, thick, closed),
ripen the cervix using prostaglandins or a Foley catheter or deliver by
caesarean section.
SEVERE PRE-ECLAMPSIA AND
ECLAMPSIA
Severe pre-eclampsia and
eclampsia are managed similarly with the exception that delivery must occur
within 12 hours of onset of convulsions in eclampsia. ALL cases of severe
pre-eclampsia should be managed actively. Symptoms and signs of “impending
eclampsia” (blurred vision, hyperreflexia) are unreliable and expectant
management is not recommended.
MANAGEMENT DURING A
CONVULSION
• Give anticonvulsive drugs.
• Gather equipment (airway,
suction, mask and bag, oxygen) and give oxygen at 4–6 L per minute.
• Protect the woman from
injury but do not actively restrain her.
• Place the woman on her
left side to reduce risk of aspiration of secretions, vomit and blood.
• After the convulsion,
aspirate the mouth and throat as necessary.
GENERAL MANAGEMENT
• If diastolic blood
pressure remains above 110 mm Hg, give
antihypertensive drugs. Reduce the diastolic blood pressure to less than 100
mm Hg but not below 90 mm Hg.
•
Start an IV infusion and infuse IV fluids.
• Maintain a strict fluid
balance chart and monitor the amount of fluids administered and urine output to
ensure that there is no fluid overload.
• Catheterize the bladder to
monitor urine output and proteinuria.
• If urine output is less
than 30 mL per hour:
- Withhold magnesium
sulfate and infuse IV fluids (normal saline or Ringer’s lactate) at 1 L in 8
hours;
- Monitor for the
development of pulmonary oedema.
• Never leave the woman
alone. A convulsion followed by aspiration of vomit may cause death of the
woman and fetus.
• Observe vital signs,
reflexes and fetal heart rate hourly.
• Auscultate the lung bases
hourly for rales indicating pulmonary oedema. If rales are heard,
withhold fluids and give frusemide 40 mg IV once.
• Assess clotting status
with a bedside
clotting test. Failure of a clot to form after 7 minutes or a soft clot that
breaks down easily suggests
coagulopathy.
ANTICONVULSIVE DRUGS
A key factor in
anticonvulsive therapy is adequate administration of anticonvulsive drugs.
Convulsions in hospitalized women are most frequently caused by
under-treatment. Magnesium sulfate is the drug of choice for preventing and
treating convulsions in severe pre-eclampsia and eclampsia. Administration
is outlined in Box S-3.
If magnesium sulfate is
not available, diazepam may be used although there is a greater risk for
neonatal respiratory depression because diazepam passes the placenta freely. A
single dose of diazepam to abort a convulsion seldom causes neonatal respiratory
depression. Long-term continuous IV administration increases the risk of
respiratory depression in babies who may already be suffering from the effects
of utero-placental ischaemia and preterm birth. The effect may last several
days. Administration of diazepam is outlined in Box S-4.
BOX S-3 Magnesium sulfate
schedules for severe pre-eclampsia and eclampsia
Loading dose
• Magnesium sulfate 20%
solution, 4 g IV over 5 minutes.
• Follow promptly with 10
g of 50% magnesium sulfate solution, 5 g in each buttock as deep IM
injection with 1 mL of 2% lignocaine in the same syringe.
Ensure that aseptic
technique is practiced when giving magnesium sulfate deep IM injection.
Warn the woman that a feeling of warmth will be felt when magnesium
sulfate is given.
• If convulsions recur
after 15 minutes, give 2 g magnesium sulfate (50% solution) IV over 5
minutes.
Maintenance dose
• 5 g magnesium sulfate
(50% solution) + 1 mL lignocaine 2% IM every 4 hours into alternate
buttocks.
• Continue treatment with
magnesium sulfate for 24 hours after delivery or the last convulsion,
whichever occurs last.
Before repeat
administration, ensure that:
• Respiratory rate is at
least 16 per minute.
• Patellar reflexes are
present.
• Urinary output is at
least 30 mL per hour over 4 hours.
WITHHOLD OR DELAY DRUG
IF:
• Respiratory rate falls
below 16 per minute.
• Patellar reflexes are
absent.
• Urinary output falls
below 30 mL per hour over preceding 4 hours.
Keep antidote ready
• In case of respiratory
arrest:
Assist ventilation (mask
and bag, anaesthesia apparatus, intubation). Give calcium gluconate 1 g
(10 mL of 10% solution) IV slowly until respiration begins to antagonize
the effects of magnesium sulfate. |
BOX S-4 Diazepam schedules
for severe pre-eclampsia and eclampsia
Note: Use
diazepam only if magnesium sulfate is not available.
Intravenous administration
Loading dose
• Diazepam 10 mg IV
slowly over 2 minutes.
• If convulsions recur,
repeat loading dose.
Maintenance dose
• Diazepam 40 mg in 500
mL IV fluids (normal saline or Ringer’s lactate) titrated to keep the
woman sedated but rousable.
• Maternal respiratory
depression may occur when dose exceeds 30 mg in 1 hour:
Assist ventilation
(mask and bag, anaesthesia apparatus, intubation), if necessary.
Do not give more than 100 mg in 24 hours.
Rectal
administration
• Give diazepam rectally
when IV access is not possible. The loading dose is 20 mg in a 10 mL
syringe. Remove the needle, lubricate the barrel and insert the syringe
into the rectum to half its length. Discharge the contents and leave the
syringe in place, holding the buttocks together for 10 minutes to prevent
expulsion of the drug. Alternatively, the drug may be instilled in the
rectum through a catheter.
• If convulsions are
not controlled within 10 minutes, administer an additional 10 mg per
hour or more, depending on the size of the woman and her clinical
response. |
ANTIHYPERTENSIVE DRUGS
If the diastolic pressure
is 110 mm Hg or more, give antihypertensive drugs. The goal is to keep the
diastolic pressure between 90 mm Hg and 100 mm Hg to prevent cerebral
haemorrhage. Hydralazine is the drug of choice.
• Give hydralazine 5 mg IV
slowly every 5 minutes until blood pressure is lowered. Repeat hourly as needed
or give hydralazine 12.5 mg IM every 2 hours as needed.
• If hydralazine is not
available, give:
- labetolol 10 mg IV:
- If response is
inadequate (diastolic blood pressure remains above 110 mm Hg) after 10
minutes, give labetolol 20 mg IV;
- Increase the dose to 40
mg and then 80 mg if satisfactory response is not obtained after 10 minutes of
each dose;
- OR nifedipine 5 mg under
the tongue:
- If response is
inadequate (diastolic pressure remains above 110 mm Hg) after 10 minutes,
give an additional 5 mg under the tongue.
Note: There is
concern regarding a possibility for an interaction with magnesium sulfate that
can lead to hypotension.
DELIVERY
Delivery should take place
as soon as the woman’s condition has stabilized. Delaying delivery to increase
fetal maturity will risk the lives of both the woman and the fetus. Delivery
should occur regardless of the gestational age.
In severe pre-eclampsia,
delivery should occur within 24 hours of the onset of symptoms. In eclampsia,
delivery should occur within 12 hours of the onset of convulsions.
•
Assess the cervix.
• If the cervix is
favourable (soft, thin, partly dilated),
rupture the membranes with an amniotic hook or a Kocher clamp and induce labour
using oxytocin or prostaglandins.
• If vaginal delivery is
not anticipated within 12 hours (for eclampsia) or 24 hours (for severe pre-eclampsia),
deliver by
caesarean section.
• If there are fetal
heart rate abnormalities (less than 100 or more than 180 beats per minute),
deliver by
caesarean section.
• If the cervix is
unfavourable (firm, thick, closed) and the fetus is alive, deliver by
caesarean section.
• If safe anaesthesia is
not available for caesarean section or if the fetus is dead or too
premature for survival:
- Aim for vaginal
delivery;
- If the cervix is
unfavourable (firm, thick, closed),
ripen the cervix using misoprostol, prostaglandins or a Foley catheter.
Note: If caesarean
section is performed, ensure that:
• Coagulopathy has been
ruled out;
• Safe general anaesthesia
is available. Spinal anaesthesia is associated with the risk of hypotension.
This risk can be reduced if adequate IV fluids (500–1 000 mL) are infused prior
to administration of the anaesthetic.
Do not use local anaesthesia
or ketamine in women with pre-eclampsia or eclampsia.
POSTPARTUM CARE
• Anticonvulsive therapy
should be maintained for 24 hours after delivery or the last convulsion,
whichever occurs last.
• Continue antihypertensive
therapy as long as the diastolic pressure is 110 mm Hg or more.
• Continue to monitor urine
output.
REFERRAL FOR TERTIARY LEVEL
CARE
Consider referral of women
who have:
• oliguria that persists for
48 hours after delivery;
• coagulation failure [e.g.
coagulopathy or haemolysis, elevated liver enzymes and low platelets (HELLP)
syndrome];
• persistent coma lasting
more than 24 hours after convulsion.
COMPLICATIONS OF
PREGNANCY-INDUCED HYPERTENSION
Complications may cause
adverse perinatal and maternal outcomes. Because complications are often
difficult to treat, efforts should be made to prevent them by early diagnosis
and proper management. Health care providers should be aware that management can
also lead to complications. Manage complications as follows:
• If fetal growth
restriction is severe, expedite delivery.
• If there is increasing
drowsiness or coma, suspect cerebral haemorrhage:
- Reduce blood pressure
slowly to reduce the risk of cerebral haemorrhage;
- Provide supportive
therapy.
• If heart, kidney or
liver failure is suspected, provide supportive therapy and observe.
• If a clotting test shows
failure of a clot to form after 7 minutes or a soft clot that breaks down
easily, suspect
coagulopathy.
• If the woman has IV
lines and catheters, she is prone to infection.
Use proper infection prevention techniques and closely monitor for signs of
infection.
• If the woman is
receiving IV fluids, she is at risk of circulatory overload. Maintain a
strict fluid balance chart and monitor the amount of fluids administered and
urine output.
CHRONIC HYPERTENSION
• Encourage additional
periods of rest.
• High levels of blood
pressure maintain renal and placental perfusion in chronic hypertension;
reducing blood pressure will result in diminished perfusion. Blood pressure
should not be lowered below its pre-pregnancy level. There is no evidence that
aggressive treatment to lower the blood pressure to normal levels improves
either fetal or maternal outcome:
- If the woman was on
anti-hypertensive medication before pregnancy and the disease is
well-controlled, continue the same medication if acceptable in pregnancy;
- If diastolic blood
pressure is 110 mm Hg or more, or systolic blood pressure is 160 mm Hg or
more, treat with antihypertensive drugs;
- If proteinuria or
other signs and symptoms are present, consider superimposed pre-eclampsia
and manage as mild pre-eclampsia.
• Monitor fetal growth and
condition.
• If there are no
complications, deliver at term.
• If pre-eclampsia
develops, manage as mild pre-eclampsia
or severe pre-eclampsia.
• If there are fetal
heart rate abnormalities (less than 100 or more than 180 beats per minute),
suspect fetal distress.
• If fetal growth
restriction is severe and pregnancy dating is accurate,
assess the cervix and consider delivery:
Note: Assessment of
gestation by ultrasound in late pregnancy is not accurate.
- If the cervix is
favourable (soft, thin, partly dilated),
rupture the membranes with an amniotic hook or a Kocher clamp and induce
labour using oxytocin or prostaglandins;
- If the cervix is
unfavourable (firm, thick, closed),
ripen the cervix using prostaglandins or a Foley catheter.
• Observe for complications
including
abruptio placentae and superimposed pre-eclampsia .
TETANUS
Clostridium tetani
may enter the uterine cavity on unclean instruments or hands, particularly
during non-professional abortions or non-institutional deliveries. The newborn
is usually infected from unclean instruments used in cutting the cord or from
contaminated substances applied as traditional cord dressings.
Treatment should begin as
soon as possible.
• Control spasms with
diazepam 10 mg IV slowly over 2 minutes. If spasms are severe, the woman
may have to be paralyzed and put on a ventilator. This may be possible only at a
tertiary care centre.
• Provide general care:
- Nurse in a quiet room
but monitor closely;
- Avoid unnecessary
stimuli;
- Maintain hydration and
nutrition;
- Treat secondary
infection.
• Give tetanus antitoxin 3
000 units IM to neutralize absorbed toxin.
• Prevent further production
of toxin:
- Remove the cause of
sepsis (e.g. remove infected tissue from uterine cavity in a septic abortion);
- Give benzyl penicillin 2
million units IV every 4 hours for 48 hours, then give ampicillin 500 mg by
mouth three times per day for 10 days.
BOX S-5 Tetanus
immunization
When the mother has
active immunity, the antibodies pass through the placenta, protecting the
newborn. A woman is considered protected when she has received two vaccine
doses at least 4 weeks apart and with an interval of at least 4 weeks
between the last vaccine dose and pregnancy termination. Women who have
received a vaccination series (five injections) more than 10 years before
the present pregnancy should be given a booster. In most women a booster
is recommended in every pregnancy.
If an immunized woman has
had an unsafe abortion or unhygienic delivery, give her a booster
injection of tetanus toxoid 0.5 mL IM. If she has not been immunized
before, give her anti-tetanus serum 1 500 units IM followed by a
booster injection of tetanus toxoid 0.5 mL IM after 4 weeks. |
EPILEPSY
Women with epilepsy can
present with convulsions in pregnancy. Like many chronic diseases, epilepsy
worsens in some women during pregnancy but improves in others. In the majority
of women, however, epilepsy is unaffected by pregnancy.
• Observe the woman closely.
In general, pregnant women with epilepsy have an increased risk of:
- pregnancy-induced
hypertension;
- preterm labour;
- infants with low birth
weights;
- infants with congenital
malformations;
- perinatal mortality.
• Aim to control epilepsy
with the smallest dose of a single drug. Avoid drugs in early pregnancy which
are associated with congenital malformations (e.g. valproic acid).
• If the woman is
convulsing, give diazepam 10 mg IV slowly over 2 minutes. Repeat if
convulsions recur after 10 minutes.
• If convulsions continue
(status epilepticus), infuse phenytoin 1 g (approximately 18 mg/kg body weight)
in 50–100 mL normal saline over 30 minutes (final concentration not to exceed 10
mg per mL):
Note: Only normal saline
can be used to infuse phenytoin. All other IV fluids will cause
crystallization of phenytoin.
- Flush IV line with
normal saline before and after infusing phenytoin;
- Do not infuse phenytoin
at a rate exceeding 50 mg per minute due to the risk of irregular heart beat,
hypotension and respiratory depression;
- Complete administration
within 1 hour of preparation.
• If the woman is known
to be epileptic, give her the same medication that she had been taking.
Follow-up with her regularly and adjust the dose of medication according to the
response.
• If the woman is known
to be epileptic but cannot recall details of her medication, give her
phenytoin 100 mg by mouth three times per day. Follow her up regularly and
adjust the dose of medication according to the clinical situation.
• Folic acid deficiency may
be caused by anticonvulsive drugs. Give folic acid 600 mcg by mouth once daily
along with antiepileptic treatment in pregnancy.
• Phenytoin can cause
neonatal deficiency of vitamin K-dependent clotting factors. This can be
minimized by giving vitamin K 1 mg IM to the newborn.
• Evaluation for underlying
causes of convulsions is indicated if convulsions are of recent onset. This may
be possible only at the tertiary care level.
SEVERE/COMPLICATED
MALARIA
Severe malaria in pregnancy
may be misdiagnosed as eclampsia. If a pregnant woman living in a malarial
area has fever, headaches or convulsions and malaria cannot be excluded, it is
essential to treat the woman for both malaria and eclampsia.
Pregnant women with severe
malaria are particularly prone to hypoglycaemia, pulmonary oedema, anaemia and
coma.
ANTIMALARIAL DRUGS
Quinine remains the first
line treatment in many countries and may be safely used throughout pregnancy.
Where available, artesunate IV or artemether IM are the drugs of choice in the
second and third trimesters. Their use in the first trimester must balance their
advantages over quinine (better tolerability, less hypoglycaemia) against the
limited documentation of pregnancy outcomes.
QUININE DIHYDROCHLORIDE
LOADING
DOSE
• Infuse quinine
dihydrochloride 20 mg/kg body weight in IV fluids (5% dextrose, normal saline or
Ringer’s lactate) over 4 hours:
- Never give an IV
bolus injection of quinine;
- If it is definitely
known that the woman has taken an adequate dose of quinine (1.2 g) within
the preceding 12 hours, do not give the loading dose. Proceed with the
maintenance dose (see below);
- If the history of
treatment is not known or is unclear, give the loading dose of quinine;
- Use 100–500 mL IV fluids
depending on the fluid balance state.
• Wait 4 hours before giving
the maintenance dose.
MAINTENANCE
DOSE
• Infuse quinine
dihydrochloride 10 mg/kg body weight over 4 hours. Repeat every 8 hours (i.e.
quinine infusion for 4 hours, no quinine for 4 hours, quinine infusion for 4
hours, etc.).
Note: Monitor blood glucose levels for hypoglycaemia
every hour while the woman is receiving quinine IV.
• Continue the maintenance
dosing schedule until the woman is conscious and able to swallow and then give:
- quinine dihydrochloride
or quinine sulfate 10 mg/kg body weight by mouth every 8 hours to complete 7
days of treatment;
- OR in areas where
sulfadoxine/pyrimethamine is effective, give sulfadoxine/pyrimethamine 3
tablets as a single dose.
INTRAVENOUS ARTESUNATE
LOADING DOSE
• Give artesunate 2.4 mg/kg
body weight IV as a single bolus on the first day of treatment.
MAINTENANCE
DOSE
• Give artesunate 1.2 mg/kg
body weight IV as a single bolus once daily beginning on the second day of
treatment.
• Continue the maintenance
dosing schedule until the woman is conscious and able to swallow and then give
artesunate 2 mg/kg body weight by mouth once daily to complete 7 days of
treatment.
INTRAMUSCULAR
ARTEMETHER
LOADING DOSE
• Give artemether 3.2 mg/kg
body weight IM as a single dose on the first day of treatment.
MAINTENANCE
DOSE
• Give artemether 1.6 mg/kg
body weight IM once daily beginning on the second day of treatment.
• Continue the maintenance
dosing schedule until the woman is conscious and able to swallow and then give
artesunate 2 mg/kg body weight by mouth once daily to complete 7 days of
treatment.
CONVULSIONS
• If convulsions occur,
give diazepam 10 mg IV slowly over 2 minutes.
• If eclampsia is
diagnosed, prevent subsequent convulsions with magnesium sulfate (Box
S-3).
• If eclampsia is
excluded, prevent subsequent convulsions with phenytoin (below).
PHENYTOIN
LOADING DOSE
• Infuse phenytoin 1 g
(approximately 18 mg/kg body weight) in 50–100 mL normal saline over 30 minutes
(final concentration not to exceed 10 mg per mL):
Note: Only normal saline
can be used to infuse phenytoin. All other IV fluids will cause
crystallization of phenytoin.
- Flush IV line with
normal saline before and after infusing phenytoin;
- Do not infuse phenytoin
at a rate exceeding 50 mg per minute due to the risk of irregular heart beat,
hypotension and respiratory depression;
- Complete administration
within 1 hour of preparation.
MAINTENANCE
DOSE
• Give phenytoin 100 mg IV
slowly over 2 minutes or by mouth every 8 hours beginning at least 12 hours
after the loading dose.
FLUID BALANCE
• Maintain a strict fluid
balance chart and monitor the amount of fluids administered and urine output to
ensure that there is no fluid overload. Assess clinical status regularly.
Note: Women with
severe malaria are prone to fluid overload.
• If pulmonary oedema
develops:
- Prop the woman up;
- Give oxygen at 4 L per
minute by mask or nasal cannulae;
- Give frusemide 40 mg IV
as a single dose.
• If urine output is poor
(less than 30 mL per hour):
- Measure serum creatinine;
- Rehydrate with IV fluids
(normal saline, Ringer’s lactate).
• If urine output does
not improve, give frusemide 40 mg IV as a single dose and monitor urine
output.
• If urine output is
still poor (less than 30 mL per hour over 4 hours) and the serum
creatinine is more than 2.9 mg/dL, refer the woman to a tertiary care centre
for management of renal failure.
HYPOGLYCAEMIA
Hypoglycaemia is common and
occurs at any time during the illness, especially after initiation of quinine
therapy. There may be no symptoms.
• Monitor blood glucose
levels using a stix test every 4 hours.
Note: If the woman
is receiving quinine IV, monitor blood glucose levels every hour.
• If hypoglycaemia is
detected, give 50% dextrose 50 mL IV followed by dextrose (5 or 10%) 500 mL
infused over 8 hours.
Note: Monitor blood
glucose levels and adjust infusion accordingly.
• Monitor fluid balance carefully.
ANAEMIA
Complicated malaria is often
accompanied by anaemia.
• Monitor haemoglobin levels
daily.
•
Transfuse as necessary.
• Monitor fluid balance.
• Give frusemide 20 mg IV or
by mouth with each unit of blood.
• Give ferrous sulfate or
ferrous fumerate 60 mg by mouth PLUS folic acid 400 mcg by mouth once daily upon
discharge.
|